Work

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.

Year: 1998

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1998.16.7.2382

Authors: J H Fetting, R Gray, D L Fairclough, T J Smith, K A Margolin, M L Citron, M Grove-Conrad, D Cella, K Pandya, N Robert, I C Henderson, C K Osborne, M D Abeloff

Institutions: Johns Hopkins University, Johns Hopkins Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1422427855, G3337849518, City of Hope Southwest Oncology Group Clinical Trials, Eastern Cooperative Oncology Group, G5765316850, ECOG Statistical Office

OpenAlex ID: W1884611568

FWCI: 1.54

Cites: 29

Cited by: 42

Related to: 10